======= HDAC7 ======= == Gene Information == * **Official Symbol**: HDAC7 * **Official Name**: histone deacetylase 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51564|51564]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WUI4|Q8WUI4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HDAC7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HDAC7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606542|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Hist deacetyl| |NAD-dependent histone deacetylase activity (H3-K14 specific)| |histone H3 deacetylation| |positive regulation of cell migration involved in sprouting angiogenesis| |negative regulation of NIK/NF-kappaB signaling| |negative regulation of interleukin-2 production| |14-3-3 protein binding| |activating transcription factor binding| |histone deacetylase complex| |regulation of cell migration involved in sprouting angiogenesis| |repressing transcription factor binding| |positive regulation of sprouting angiogenesis| |negative regulation of osteoblast differentiation| |histone deacetylation| |protein deacetylation| |protein kinase C binding| |regulation of interleukin-2 production| |positive regulation of blood vessel endothelial cell migration| |protein deacylation| |macromolecule deacylation| |vasculogenesis| |regulation of sprouting angiogenesis| |negative regulation of ossification| |regulation of blood vessel endothelial cell migration| |positive regulation of endothelial cell migration| |cell-cell junction assembly| |regulation of NIK/NF-kappaB signaling| |regulation of osteoblast differentiation| |cell-cell junction organization| |positive regulation of epithelial cell migration| |regulation of endothelial cell migration| |positive regulation of angiogenesis| |cell junction assembly| |positive regulation of vasculature development| |regulation of ossification| |cell junction organization| |regulation of epithelial cell migration| |transcription corepressor activity| |negative regulation of cytokine production| |regulation of angiogenesis| |regulation of vasculature development| |histone modification| |covalent chromatin modification| |chromatin binding| |blood vessel morphogenesis| |protein kinase binding| |blood vessel development| |positive regulation of cell migration| |negative regulation of intracellular signal transduction| |vasculature development| |cardiovascular system development| |positive regulation of cell motility| |positive regulation of cellular component movement| |positive regulation of locomotion| |tube morphogenesis| |regulation of cytokine production| |chromatin organization| |negative regulation of cell differentiation| |tube development| |regulation of cell migration| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |regulation of cell motility| |negative regulation of developmental process| |regulation of locomotion| |regulation of cellular component movement| |regulation of anatomical structure morphogenesis| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of response to stimulus| |negative regulation of gene expression| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|1.77| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.92| |[[:results:exp512|Olaparib 4μM R08 exp512]]|1.93| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|2.15| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|2.31| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|2.39| |[[:results:exp502|Milciclib 2μM R08 exp502]]|3.91| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 3/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/25| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|1/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13091 * **Expression level (log2 read counts)**: 5.96 {{:chemogenomics:nalm6 dist.png?nolink |}}